CAS 2378114-72-6

Lanreotide acetate

CAS : 2378114-72-6

Lanreotide acetate

Degré de pureté : ≥98%

Masse moléculaire : 1156.39g/mol

Ref: 54-BUP05664

Lanreotide acetate

CAS : 2378114-72-6

Lanreotide acetate (BIM 23014 acetate) is a somatostatin analogue with antineoplastic activity, used for carcinoid syndrome

Formule : C₅₆H₇₃N₁₁O₁₂S₂

Degré de pureté : >99.99%

Couleur et forme : Solid

Masse moléculaire : 1156.39

Ref: TM-T8359

Lanreotide

CAS : 2378114-72-6

Lanreotide acetate salt H-D-2-Nal-Cys-Tyr-D-Trp-Lys-Val-Cys-Thr-NH2 acetate salt (Disulfide bond) is a peptide hormone that binds to the voltage dependent calcium channels. It is used to treat acromegaly, carcinoid syndrome and infectious diseases. Lanreotide acetate has been shown to inhibit the growth of solid tumours in animal models. Side effects of lanreotide acetate include cardiac effects, such as QTc interval prolongation, and somatostatin release. It also has toxicity studies for use in humans.

Formule : C₅₄H₆₉N₁₁O₁₀S₂

Degré de pureté : Min. 95%

Masse moléculaire : 1,096.33 g/mol

Ref: 3D-FL110376